Sambrosa
- Product NDC
- 60665-003
- 11-digit product format
- 606650003
- Labeler code
- 60665
- Product ID
- 60665-003_47ceb0bf-5593-9021-e063-6294a90a4ce1
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- DOXYLAMINE SUCCINATE
- Dosage form
- SYRUP
- Route
- ORAL
- Labeler
- Sambrosa Care, Inc.
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-01-10
- Substance
- DOXYLAMINE SUCCINATE
- Active strength
- 9.78 mg/3mL
- Pharmacologic classes
- Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 60665-003-04 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 60665-003-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 60665-003-03 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 60665-003-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 60665-003-04 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 60665-003-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 60665-003-03 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 60665-003-01 | f5e01cc5f278… | a2eaf40c39c3… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sambrosa
- Brand name suffix
- Night
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOXYLAMINE SUCCINATE | 9.78 mg/3mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V9BI9B5YI2 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2390292 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| acdc8740-6231-d1e8-e053-2995a90a3b8d | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 59361619-24d9-b610-eca6-5a7f25ed5e03 | Product name | 5 | 20240909 |
| f4368033-af8c-41bf-a84b-ff77392b8522 | Product name | 1 | 20161229 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 60665-003-01 | 2026-01-13 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-02 | 2026-01-13 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-03 | 2026-01-13 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-04 | 2026-01-13 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-01 | 2025-07-29 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-02 | 2025-07-29 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-03 | 2025-07-29 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-04 | 2025-07-29 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60665-003-01 | SambrosaNight | 100 mL in 1 BOTTLE | SYRUP | 100 | 8 | |
| 60665-003-01 | SambrosaNight | 1 in 1 CARTON | SYRUP | 1 | 8 | |
| 60665-003-02 | SambrosaNight | 1 in 1 CARTON | SYRUP | 1 | 8 | |
| 60665-003-02 | SambrosaNight | 30 mL in 1 BOTTLE | SYRUP | 30 | 8 | |
| 60665-003-03 | SambrosaNight | 300 mL in 1 BOTTLE | SYRUP | 300 | 8 | |
| 60665-003-03 | SambrosaNight | 1 in 1 CARTON | SYRUP | 1 | 8 | |
| 60665-003-04 | SambrosaNight | 3 mL in 1 POUCH | SYRUP | 3 | 8 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nighttime Ultra Concentrated Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE SOFTGELS | WALGREENS | 2be0a699-e6ad-ef56-e063-6394a90aaca5 | 2025-04-03 | Warnings | M012 |
| Cough and Congestion | DEXTROMETHORPHAN HBR, GUAIFENESIN | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 44fb27d3-5125-4511-84d2-76555bc46e66 | 2025-04-03 | Warnings | M012 |
| Guaifenesin | GUAIFENESIN | KESIN PHARMA CORPORATION | 31b8ad0a-3637-03db-e063-6394a90acdc3 | 2025-04-01 | Warnings | M012 |
| Pharmacys Prescription Vapor Rub | MENTHOL | American Consumer Products Corp | 31aa54d8-df8d-f1ae-e063-6294a90a9622 | 2025-03-31 | Warnings | M012 |
| Guaifenesin | GUAIFENESIN | Bryant Ranch Prepack | 570a71eb-2d19-4c7b-8c00-e1524bfa3844 | 2025-03-31 | Warnings | M012 |
| Guaifenesin | GUAIFENESIN | KESIN PHARMA CORPORATION | 365c01b7-a197-4876-85fc-42204f787e3a | 2025-03-28 | Warnings | M012 |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | Bryant Ranch Prepack | 59aeb692-2f79-45aa-8e6a-dab77cd3b2f9 | 2025-03-28 | Warnings | M012 |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Oncor Pharmaceuticals | 06ecba97-c790-4672-a8c3-f9caf6272d26 | 2025-03-27 | Warnings | M012 |
| Sugar Free Honey-Lemon Fishermans Friend Menthol Cough Suppressant | MENTHOL | Lofthouse of Fleetwood, Ltd. | 87ebb4d9-78d7-1c87-e053-2a95a90adb7d | 2025-03-27 | Warnings | M012 |
| REVASOL CHILDRENS ALLERGY | DIPHENHYDRAMINE HCL | Rnv LLC | 3143137f-ef42-5358-e063-6394a90a8ed1 | 2025-03-26 | Warnings | M012 |
| Rompe Pecho SF FLU | DEXTROMETHORPHAN, BROMPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE | Efficient Laboratories Inc | bc10695a-9664-4ce3-82bb-820da06129fa | 2025-03-26 | Warnings | M012 |
| SUPRESS-PE Pediatric | GUIAFENESIN, PHENYLEPHRINE HCL | Kramer Novis | a474171d-5c29-4a80-9d37-00613796211a | 2025-03-26 | Warnings | M012 |
| Guaifenesin DM | DEXTROMETHORPHAN HYDROBROMIDE,GUAIFENESIN | Innovida Pharmaeutique Corporation | dd3f806b-2470-4055-94e1-18adac811025 | 2025-03-25 | Warnings | M012 |
| Foster and Thrive childrens cold cough relief dm | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE | Strategic Sourcing Services LLC | 38b710e3-1d01-4ff4-a6b6-44936f277f49 | 2025-03-25 | Warnings | M012 |
| Revasol Tussin DM Max with Honey | DEXTROMETHORPHAN HBR AND GUAIFENESIN | Rnv LLC | 30da9255-c93a-84d6-e063-6394a90a7c2a | 2025-03-21 | Warnings | M012 |
| REVASOL NIGHTTIME COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR AND DOXYLAMINE SUCCINATE | Rnv LLC | 30dfd8f7-4cc6-d4f2-e063-6394a90aa9c9 | 2025-03-21 | Warnings | M012 |
| Chest Congestion Relief | GUAIFENESIN | Meijer, Inc. | 261a79b3-5704-76f2-e063-6394a90a5ac6 | 2025-03-20 | Warnings | M012 |
| Rompe Tos X Children | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05cc932d-b412-0710-e063-6394a90a87f6 | 2025-03-19 | Warnings | M012 |
| Rompe Tos X Adults | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05abb2db-d22e-90b5-e063-6294a90ace3f | 2025-03-19 | Warnings | M012 |
| Sinus Head Congestion | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE | VIVUNT PHARMA LLC | 30a07773-bd6f-b9f2-e063-6394a90ab8aa | 2025-03-18 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2390292 | doxylamine succinate 9.78 MG in 3 mL Oral Solution | PSN | acdc8740-6231-d1e8-e053-2995a90a3b8d | 8 |
| 2390292 | doxylamine succinate 3.26 MG/ML Oral Solution | SCD | acdc8740-6231-d1e8-e053-2995a90a3b8d | 8 |
| 2390292 | doxylamine succinate 9.78 MG per 3 mL Oral Solution | SY | acdc8740-6231-d1e8-e053-2995a90a3b8d | 8 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 60665-003-01 | 60665000301 | 1 BOTTLE in 1 CARTON (60665-003-01) / 100 mL in 1 BOTTLE | 1 bottle | 2020-01-10 | 0000-00-00 | No | No | Current |
| 60665-003-02 | 60665000302 | 1 BOTTLE in 1 CARTON (60665-003-02) / 30 mL in 1 BOTTLE | 1 bottle | 2020-12-01 | 0000-00-00 | No | No | Current |
| 60665-003-03 | 60665000303 | 1 BOTTLE in 1 CARTON (60665-003-03) / 300 mL in 1 BOTTLE | 1 bottle | 2020-01-10 | 0000-00-00 | No | No | Current |
| 60665-003-04 | 60665000304 | 3 mL in 1 POUCH (60665-003-04) | 3 ml | 2021-10-26 | 0000-00-00 | No | No | Current |